University of Maryland-Greenebaum Comprehensive Cancer Center ( Site 0211) is a clinical research site located in Baltimore, Maryland, United States 21201.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
University of Maryland-Greenebaum Comprehensive Cancer Center ( Site 0211) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Sponsors: Merck Sharp & Dohme LLC.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Maryland-Greenebaum Comprehensive Cancer Center ( Site 0211) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Maryland-Greenebaum Comprehensive Cancer Center ( Site 0211) has 1 clinical trials on record, with 1 currently active. Their work covers Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
University of Maryland-Greenebaum Comprehensive Cancer Center ( Site 0211) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.